Diabetes

Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with respect to appropriate and necessary care for an individual patient. In the event HMSA policies differ from the clinical practice guidelines, for benefit purposes, HMSA policies shall supersede the clinical practice guidelines.

The links below direct you to the latest national guidelines (in alphabetic order):

• American Association of Clinical Endocrinology (AACE)

  2023 AACE Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm

• American Diabetes Association

  ADA Standards of Care in Diabetes – 2025

  The 2025 guidelines provide treatment updates on managing obesity in people with diabetes, emphasized screening recommendations for heart failure, NAFLD, peripheral vascular disease, bone health, and disability in people with diabetes, and embraces the utilization of technology including artificial intelligence and telehealth in diabetes management.

Guideline Review Date: December 2025

The information posted above includes hypertext links or pointers to information created and maintained by other organizations. HMSA provides these links for our users’ information and convenience. When users select a link to an outside website, they are leaving the HMSA site and are subject to the privacy and security policies of the outside website. HMSA does not control or guarantee the accuracy, relevance, timeliness, or completeness of information on linked websites. HMSA does not endorse the organizations sponsoring linked websites and we do not endorse the views they express or the products/services they offer. HMSA cannot authorize the use of copyrighted materials in linked websites; users must request such authorization from the sponsor of the linked website. HMSA is not responsible for transmissions users receive from linked websites.

Revision History